Inhibition of Forkhead Box O1 Protects Pancreatic β-Cells against Dexamethasone-Induced Dysfunction
Authors:
- 14 May 2009
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (9) , 4065-4073
Abstract
Forkhead Box O1 (FoxO1) is a key transcription regulator of insulin/IGF-I signaling pathway, and its activity can be increased by dexamethasone (DEX) in several cell types. However, the role of FoxO1 in DEX-induced pancreatic β-cell dysfunction has not been fully understood. Therefore, in this study, we investigated whether FoxO1 could mediate DEX-induced β-cell dysfunction and the possible underlying mechanisms in pancreatic β-cell line RINm5F cells and primary rat islet. We found that DEX markedly increased FoxO1 mRNA and protein expression and decreased FoxO1 phosphorylation through the Akt pathway, which resulted in an increase in active FoxO1 in RINm5F cells and isolated rat islets. Activated FoxO1 subsequently inhibited pancreatic duodenal homeobox-1 expression and induced nuclear exclusion of pancreatic duodenal homeobox-1. Knockdown of FoxO1 by RNA interference restored the expression of pancreatic duodenal homeobox-1 and prevented DEX-induced dysfunction of glucose-stimulated insulin secretion in rat islets. Together, the results of present study demonstrate that FoxO1 is integrally involved in DEX-induced inhibition of pancreatic duodenal homeobox-1 and glucose-stimulated insulin secretion dysfunction in pancreatic islet β-cells. Inhibition of FoxO1 can effectively protect β-cells against DEX-induced dysfunction.Keywords
This publication has 49 references indexed in Scilit:
- Inhibition of Foxo1 Protects Pancreatic Islet β-Cells Against Fatty Acid and Endoplasmic Reticulum Stress–Induced ApoptosisDiabetes, 2008
- Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitorDiabetologia, 2005
- Dissecting the Role of Glucocorticoids on Pancreas DevelopmentDiabetes, 2004
- FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and TransformationCell, 2004
- The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growthJournal of Clinical Investigation, 2002
- Mechanisms involved in the side effects of glucocorticoidsPharmacology & Therapeutics, 2002
- Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytesEuropean Journal of Endocrinology, 2002
- The Molecular Physiology of Hepatic Nuclear Factor 3 in the Regulation of GluconeogenesisJournal of Biological Chemistry, 2000
- DRUG SELECTION AND THE MANAGEMENT OF CORTICOSTEROID-RELATED DIABETES MELLITUSRheumatic Disease Clinics of North America, 1999
- Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.Journal of Clinical Investigation, 1997